At Harvard Medical International, Changes Afoot

Since its inception, it has developed more than 50 programs, in more than 30 countries across five continents. The website lists more than two dozen projects currently under way...

Harvard Medical International (HMI), a nonprofit subsidiary of Harvard Medical School that provides medical consulting services to international clients, may be facing major changes.

In the organization's 2007 annual report, released last month, acting president and CEO Andrew A. Jeon said HMI spent the year "working on our own strategy for the future" and would continue "to explore new models." The Harvard Crimson reported today that the medical school planned to spin off HMI to Partners Healthcare, the hospital system founded by the Harvard-affiliated Brigham and Women's Hospital and Massachusetts General Hospital. Officials at HMI referred questions to the University news office, which would not comment on the matter.

Harvard Medical International was founded in 1994, when Daniel C. Tosteson was dean of the medical school. HMI's first president, clinical professor of anaesthesia Robert K. Crone, was succeeded by Jeon in November. According to its website, HMI has a staff of several dozen employees and an annual budget of $21 million, funded with revenue from its programs, rather than from the University. Since its inception, it has developed more than 50 programs, in more than 30 countries across five continents.

The website lists more than two dozen projects currently under way. For instance, HMI is providing advice and input on the design and operation of a medical school at Alfaisal University in Riyadh, Saudi Arabia. It is supporting the development and implementation of a quality-improvement program at Diagnostic and Therapeutic Center of Athens Hygeia in Greece. It has a partnership with National Taiwan University College of Medicine that includes medical-student exchanges and visiting faculty fellowships. At Wockhardt Hospitals in India, HMI has helped develop facilities and clinical programs and assisted in a performance-improvement plan that led to the hospital network's international accreditation. And in its highest-profile project, HMI is advising on the development of Dubai Healthcare City, which aims to become a regional and global hub for healthcare, medical education, and life-science research.

A full report will appear in the May-June issue of Harvard Magazine.

You might also like

Harvard Alumni Affairs Databases Breached

The University is investigating the cyberattack, which may have compromised the personal information of alumni, donors, students, faculty, and staff.

Harvard Law School Releases Digital Archive of Nuremberg Trials

Thousands of documents chronicle the Nazi regime and the legal effort to exact justice.

Summers Takes Leave Amid Harvard Probe

Previously undisclosed Epstein links to Harvard affiliates leads to a University review.

Most popular

Harvard Faculty Discuss Tenure Denials

New data show a shift in when, in the process, rejections occur

Harvard Funds Student “Bridges” Projects

Eight new initiatives to build community on campus will get underway early next year. 

Harvard Symposium Tackles 400 Years of Homelessness in America

Professors explore the history of homelessness in the U.S., from colonial poor laws to today’s housing crisis

Explore More From Current Issue

Wadsworth House with green shutters and red brick chimneys, surrounded by trees and other buildings.

Wadsworth House Nears 300

The building is a microcosm of Harvard’s history—and the history of the United States.

Illustration of tiny doctors working inside a large nose against a turquoise background.

A Flu Vaccine That Actually Works

Next-gen vaccines delivered directly to the site of infection are far more effective than existing shots.

Professor David Liu smiles while sitting at a desk with colorful lanterns and a figurine in the background.

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.